• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gland Pharma Ltd Pharmaceuticals - Indian - Formulations

  • MNC Associate
  • BSE Code : 14546.0
  • ISIN : INE068V01023
1,750.60 -20 (-1.14%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    1,740.00

  • Today’s High

    1,816.90

  • Open

    1,774.00

  • Perv Close

    1,770.80

  • 52W Low

    1,277.80

  • 52W High

    2,220.95

Key Indicators

  • P/E(TTM)

    26.41

  • Mar.Cap (₹Cr.)

    28,842.26

  • Div & Yield %

    1.03

  • Book Value(₹)

    592.09

  • Debt-Equity Ratio

    -1.14

  • AGM Date

    17-Jun-2025

  • EPS

    66.14

  • P/E Ratio

    26.41

Financials Ratios

  • Debt-Equity Ratio

    0.02

  • Mar.Cap (₹Cr.)

    28,842.26

  • RONW (%)

    9.26

  • ROCE (%)

    13.44

Score Board

  • Equity (₹ in Cr.)

    16.48

  • BV (₹)

    592.10

  • Sales( ₹ in Cr.)

    4,116.15

  • NP (in Cr.)

    1,089.75

  • NP Var(%)

    4.0

  • Div%

    1800.0

  • CPS (₹)

    76.40

  • EPS (₹)

    66.10

  • Traded Value (₹ in Lakhs)

    29,146.23

  • 52 Week High

    2,220.95

  • 52 Week Low

    1,277.80

  • Price BSE

    1769.0

  • Price NSE

    1,771.00

  • Market Capital( in Cr.)

    29,146.23

  • P/C Ratio

    23.10

  • P/E Ratio

    26.70

  • Price Vs.BV

    66.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 4,167.43 3,616.53 4,400.71 3,462.88 2,633.24 2,044.20
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4,167.43 3,616.53 4,400.71 3,462.88 2,633.24 2,044.20
Other Income 166.67 240.46 223.94 134.78 139.17 85.56
Stock Adjustments -87.43 46.92 -36.69 273.49 6.90 114.15
Total Income 4,246.67 3,903.91 4,587.96 3,871.15 2,779.31 2,243.91
EXPENDITURE :            
Raw Materials 1,732.88 1,732.34 2,072.53 1,765.36 1,108.93 971.18
Power and Fuel Cost 117.20 124.84 95.05 74.59 78.50 74.03
Employee Cost 409.95 399.70 338.57 311.36 277.66 222.95
Other Manufacturing Expenses 186.92 153.84 137.19 130.84 102.23 85.50
Selling and Administration Expenses 175.97 189.65 177.43 128.44 98.54 82.52
Miscellaneous Expenses 48.31 100.99 32.61 23.51 18.82 35.86
Employee Benefit Expenses 409.95 399.70 338.57 311.36 277.66 222.95
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,671.22 2,701.35 2,853.38 2,434.10 1,684.68 1,472.05
Operating Profit 1,575.44 1,202.55 1,734.58 1,437.04 1,094.63 771.88
Interest 7.84 7.41 5.24 3.41 7.18 3.56
Gross Profit 1,567.60 1,195.14 1,729.34 1,433.63 1,087.45 768.32
Depreciation 162.11 146.74 110.30 98.78 94.59 81.96
Profit Before Tax 1,405.49 1,048.40 1,619.04 1,334.85 992.86 686.36
Current Tax 337.49 275.38 392.88 337.73 251.83 222.45
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 24.68 -2.80 14.01 0.12 -31.82 12.00
Reported Net Profit 1,043.33 775.83 1,212.16 997.01 772.86 451.91
Extraordinary Items -0.39 -39.55 3.22 0.02 12.99 -13.15
Adjusted Net Profit 1,043.72 815.38 1,208.94 996.99 759.87 465.06
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 6,010.70 5,234.88 4,022.72 3,025.72 2,252.86 1,800.95
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 7,054.03 6,010.70 5,234.88 4,022.72 3,025.72 2,252.86
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 2,000.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 20.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 63.34 47.11 73.78 60.95 49.88 291.65
Earnings Per Share(Adj)-Unit Curr 63.34 47.11 73.78 60.95 - -
Book Value 546.13 482.90 435.68 360.86 235.32 1,847.12
Book Value(Adj)-Unit Curr 546.13 482.90 435.68 360.86 - -

Shareholding Pattern

  • Promoter Group

    51.83%

  • Public Share Holding

    48.17%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 85,393,934 51.83 85,393,934 5
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 85,393,934 51.83 85,393,934 5
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 100 0.00 100 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 11,375,857 6.90 11,375,857 163
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,168,358 1.32 2,168,358 8
Mutual Funds / UTI 51,340,704 31.16 51,340,704 24
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,307,400 0.79 1,307,400 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 66,192,419 40.18 66,192,419 203
2] Non Institution
Bodies Corporate 7,735,992 4.70 1,735,992 327
Clearing Members 5,196 0.00 5,196 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 347,144 0.21 347,144 2,105
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 115,743 0.07 115,743 1,653
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,000,000 0.61 1,000,000 1
Individuals holding nominal share capital up to Rs. 1 lakh 3,922,449 2.38 3,922,449 109,453
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,000 0.00 5,000 1
Others 0 0.00 0 0
Sub Total 13,170,070 7.99 7,170,070 113,580
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 164,756,423 100.00 158,756,423 113,788

Company Background

Gland Pharma LtdPharmaceuticals - Indian - Formulations

  • Gland Pharma Ltd
  • BSE Code : 14546.0
  • ISIN : INE068V01023

  • Incorporation Year

    1978

  • Registered Office

    Sy No 143-148 150&151 Nr Gandi
    X Roads D P Pally Dundigal, Hyderabad,
    Telangana-500043

  • Telephone

    91-40-30510999

  • FAX

    91-40-30510800

  • Chairman

    Yiu Kwan Stanley Lau

  • Managing Director

    SRINIVAS SADU

  • Company Secretary

  • Auditor

    Deloitte Haskins & Sells

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gland Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Gland Pharma 1,746.80 4,334.09 4,167.43 26.41 16.65
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92